0001127602-20-013334.txt : 20200406 0001127602-20-013334.hdr.sgml : 20200406 20200406171440 ACCESSION NUMBER: 0001127602-20-013334 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200402 FILED AS OF DATE: 20200406 DATE AS OF CHANGE: 20200406 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FONTEYNE PAUL R. CENTRAL INDEX KEY: 0001727550 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38276 FILM NUMBER: 20777723 MAIL ADDRESS: STREET 1: C/O RESTORBIO, INC. STREET 2: 501 BOYLSTON STREET SUITE 6102 CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001492422 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271537290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-977-5700 MAIL ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 3 1 form3.xml PRIMARY DOCUMENT X0206 3 2020-04-02 1 0001492422 Apellis Pharmaceuticals, Inc. APLS 0001727550 FONTEYNE PAUL R. C/O APELLIS PHARMACEUTICALS, INC. 100 FIFTH AVENUE, 3RD FLOOR WALTHAM MA 02451 1 /s/ David Watson, attorney-in-fact for Paul Fonteyne 2020-04-03